MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Effectiveness of Lead-Point in Parkinson`s Model of STN-MER with DBS: A Study of Predicting Motor progression

    V. Rama Raju (Hyderabad, India)

    Objective: To inquiry into the correlation between progression and active point of contact site expects an adjustment for functional (anatomical-structural) variation. Background: Within the Parkinson…
  • 2024 International Congress

    Neuropeptide Alterations in Parkinson’s Disease: A Meta-Analysis

    MA. Muneer, V. Suresh, S. Aujla, A. Khare, P. Gowda, V. Ghosh, T. Dave (Lahore, Pakistan)

    Objective: To analyze the levels of different neuropeptides in patients with Parkinson’s disease (PD) compared to healthy individuals. Background: Neuropeptides are bioactive molecules that play…
  • 2024 International Congress

    Burden of Movements Disorders at Initiative Plus Center Hospital

    P. Kiatoko, K. Luse (KINSHASA, The Democratic Republic of the Congo)

    Objective: describe the socio-demographic, clinical characteristics and evolutionary profiles of patients followed for movement disorders Background: The DR Congo specialists in abnormal movements are rare,…
  • 2024 International Congress

    Misdiagnosing Movement Disorders on a Terciary Academic Center in the Caribbean: A Series of Cases

    S. Castro, C. Torres, W. Castro, J. Carbonell, I. Zabala, A. de Peña, V. Espaillat, D. Santos, P. Roa, F. Taveras, Y. Suero (Distrito Nacional, Dominican Republic)

    Objective: To report 10 movement disorder cases misdiagnosed by general neurologists as another disorder or a different category of movement disorder. Background: The misdiagnosis of…
  • 2024 International Congress

    EMPOWER-PD: Testing and evaluation of an 8-week co-created Self-management program tailored People with Parkinson`s disease and their caregivers in an interventional follow-up study

    T. Thomsen, S. Skovbølling, M. Brønden, M. Møller, J. Frederiksen, B. Biering-Sørensen (Roskilde, Denmark)

    Objective: This study aims to test a 8-week self-management program, developed collaboratively with People with PD (PwP), caregivers, healthcare professionals and other stakeholders using a…
  • 2024 International Congress

    Scoping Review of Caregiver Burden in Parkinson’s Disease

    S. Luehrsen, I. Pretzer-Aboff, R. Brown (Richmond, USA)

    Objective: To evaluate caregiver burden and stress in Parkinson’s disease and factors that may influence different burden and stress levels. Background: N/A Method: A systematic…
  • 2024 International Congress

    Co-morbid Hypertension and Diabetes and the Relationship to Parkinson’s Disease Motor Phenotype in the Nigeria Parkinson’s Disease Research Network Registry

    E. Iwuozo, O. Ojo, O. Agabi, N. Okubadejo, NPD. Research Network (Makurdi, Nigeria)

    Objective: To determine the frequency of hypertension (HBP) and type 2 diabetes mellitus (T2DM) as comorbidities in the Nigerian PD Research network (NPDR) cohort, and…
  • 2024 International Congress

    Demographics of Botulinum toxin therapy population representative to demographics in Essex County, USA

    B. Puccio, Y. Xu, J. Acquaviva, E. Feinstein (Newark, USA)

    Objective: To describe and compare the demographics of patients receiving botulinum toxin therapy in a single movement disorder clinic to the broader surrounding community. Background:…
  • 2024 International Congress

    Altered activity of lysosomal hydrolases in monocyte-derived macrophages as potential biomarker for differential diagnosis of multiple system atrophy

    K. Basharova, A. Bezrukova, G. Baydakova, I. Miliukhina, E. Zakharova, S. Pchelina, T. Usenko (Gatchina, Russian Federation)

    Objective: The aim was to assess the possibility of differentiating synucleinopathies (Parkinson’s disease (PD), dementia with Lewy bodies (DLB), multiple system atrophy (MSA) by lysosomal…
  • 2024 International Congress

    Safety and Efficacy of the Anti-alpha Synuclein Monoclonal Antibody Lu AF82422 for the Treatment of Patients with MSA: Results from the Phase 2 AMULET Trial

    W. Singer, S. Zanigni, L. Kjærsgaard, J. Wiedemann, P. Kallunki, K. Kompus, M. Jørgensen, M. Flensburg, A. Bidani, JL. Molinuevo, A. Takeda, B. Grønning, J. Luthman (Rochester, USA)

    Objective: Assess the efficacy and safety of monthly IV infusions with the anti-alpha synuclein [a-syn] monoclonal antibody Lu AF82422 for the treatment of patients with…
  • « Previous Page
  • 1
  • …
  • 156
  • 157
  • 158
  • 159
  • 160
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley